13-methylpalmatine alleviates myocardial ischemia/reperfusion injury by potentially targeting the C5a-C5aR1 axis to inhibit neutrophil extracellular trap formation
Redox Biology · 2025-10 · 86 · 103802
DOI: 10.1016/j.redox.2025.103802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Redox Biology, 2025-10. Verfasst von Miao Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine and Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, C…. Hauptthemen laut MEDLINE: Receptor, Anaphylatoxin C5a, Myocardial Reperfusion Injury, Berberine Alkaloids, Neutrophils. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
The complement system activation-induced inflammation is a critical contributor to myocardial ischemia/reperfusion (I/R) injury. However, effective therapeutic targets and pharmacological interventions remain limited. In this study, we identified 13-methylpalmatine (13-Me-PLT), a natural isoquinoline alkaloid isolated from Coptidis chinensis, as a cardio-protective agent that improved cardiac function and reduced inflammation in a rat model of myocardial I/R injury. RNA sequencing (RNA-seq) analysis revealed significant up-regulation of neutrophil extracellular trap (NET) formation-related signaling pathway and C5ar1 gene in myocardial I/R, both of which were reversed by 13-Me-PLT treatment. Bioinformatics analysis, biophysical assays, and flow cytometry confirmed that 13-Me-PLT effectively inhibited C5a receptor 1 (C5aR1) on neutrophils. However, the role of the C5a-C5aR1 axis in NET formation during myocardial I/R injury has remained unclear. In this study, using a pharmacological inhibitor of C5aR1, we demonstrated that activation of the C5a-C5aR1 axis promoted myocardial I/R injury by inducing NET formation, and that 13-Me-PLT effectively inhibited both processes in a BM213 (C5aR1 agonist)-treated rat model. In vitro, 13-Me-PLT suppressed the expression of NET-associated proteins and alleviated fibrous NET structures in neutrophils, further supporting its cardio-protective effects. In conclusion, our findings revealed that C5a-C5aR1 axis activation exacerbated myocardial I/R injury in a NET-dependent manner. 13-Me-PLT exerted cardio-protective effects by potentially inhibiting C5a-C5aR1 axis-mediated NET formation, highlighting its potential as a therapeutic candidate for myocardial I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine and Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
- School of Traditional Chinese Medicine and Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; First Teaching Hospital of Tianjin University of Traditional Chi…
- Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang, 110819, China.
- School of Traditional Chinese Medicine and Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; School of Chinese Meteria Medica, Beijing University of Chinese…
- School of Traditional Chinese Medicine and Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China; State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKL…
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Zhang, M., Gao, S., Tan, N., Yan, Y., Zhu, R., Liu, J., Mao, Q., Wang, K., Zhang, W., Wang, G., Wang, Z., Wang, T., Huang, X., Zhang, R., & Yang, B. (2025). 13-methylpalmatine alleviates myocardial ischemia/reperfusion injury by potentially targeting the C5a-C5aR1 axis to inhibit neutrophil extracellular trap formation. Redox Biology, 86, 103802. https://doi.org/10.1016/j.redox.2025.103802
Vancouver
Zhang M, Gao S, Tan N, Yan Y, Zhu R, Liu J, et al. 13-methylpalmatine alleviates myocardial ischemia/reperfusion injury by potentially targeting the C5a-C5aR1 axis to inhibit neutrophil extracellular trap formation. Redox Biology. 2025;86:103802. doi:10.1016/j.redox.2025.103802
BibTeX
@article{Zhang2025,
author = {Zhang, Miao and Gao, Shan and Tan, Nannan and Yan, Yu and Zhu, Rongxin and Liu, Jiajing and Mao, Qin and Wang, Keyan and Zhang, Wenhao and Wang, Gang and Wang, Zhuo and Wang, Tieshan and Huang, Xueshi and Zhang, Rong and Yang, Baofeng},
title = {13-methylpalmatine alleviates myocardial ischemia/reperfusion injury by potentially targeting the C5a-C5aR1 axis to inhibit neutrophil extracellular trap formation},
journal = {Redox Biology},
year = {2025},
volume = {86},
pages = {103802},
doi = {10.1016/j.redox.2025.103802}
}
EUVIMED